Drug Shortage Report for ETOPOSIDE INJECTION USP
| Report ID | 16287 |
| Drug Identification Number | 02380935 |
| Brand name | ETOPOSIDE INJECTION USP |
| Common or Proper name | ETOPOSIDE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ETOPOSIDE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5ML VIAL |
| ATC code | L01CB |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2017-07-03 |
| Estimated end date | |
| Actual end date | 2017-07-31 |
| Shortage status | Resolved |
| Updated date | 2017-08-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2017-08-01 | English | Compare |
| v2 | 2017-07-18 | French | Compare |
| v1 | 2017-07-18 | English | Compare |
Showing 1 to 3 of 3